Nabarro advises Numis on £25.5m placing to raise additional capital for Retroscreen
Nabarro is advising existing client Numis Securities on a £25.5m placing to raise additional capital for AIM-traded Retroscreen Virology.
Retroscreen conducts research into antiviral drugs and vaccines through the use of its ‘Viral Challenge Model’, which involves infecting healthy human volunteers with a virus under controlled conditions.
The Nabarro team advising Numis in its capacity as nomad and broker for Retroscreen was led by corporate partner Alasdair Steele, assisted by senior associate Jack Shepherd and trainee Nikita Arora.
News from Nabarro
News from The Lawyer
Briefings from Nabarro
This article focuses on the reforms affecting the generation of electricity, which is a regulated sector in the UK and the EU.
The Pensions Regulator’s financial support direction case against various companies in the Lehman Brothers group has settled.
Analysis from The Lawyer
Nabarro senior partner and self-confessed “IT geek” Graham Stedman is heralding a major set of investments in technology ahead of the firm’s move to 125 London Wall this year.
Clients are more willing to bring claims against professional service providers but the risk to defendants is not as dramatic as it might seem